Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

Goiter

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Injectable Tissue-Specific Hydrogel System for Pulp-Dentin Regeneration.

Journal of dental research·2024

Same author

Efficacy of different surgical treatments for management of anal fistula: a network meta-analysis.

Techniques in coloproctology·2023

Same author

38. Effect of Chlorhexidine Rinsed Blood Contamination on Bond Strength of Brackets Bonded with Self-etch Primer- An in Vitro Study.

Mymensingh medical journal : MMJ·2023

Same author

Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration.

The British journal of dermatology·2021

Same author

Intensity warping for multisite MRI harmonization.

NeuroImage·2020

Same author

Observation of inverse Compton emission from a long γ-ray burst.

Nature·2019

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Establishment of a Modified Ferric Chloride-Induced Superior Sagittal Sinus Thrombosis

Establishment of a Modified Ferric Chloride-Induced Superior Sagittal Sinus Thrombosis

Published on: December 30, 2025

Superior sagittal sinus thrombosis secondary to hyperthyroidism.

A Dai¹, M Wasay, N Dubey

¹Department of Neurology, State University of New York at Buffalo, Buffalo, NY, USA.

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association

|September 27, 2007

Summary

Hyperthyroidism may cause superior sagittal sinus thrombosis (SSST), a dangerous blood clot in the brain. Treating thyroid dysfunction led to recovery, suggesting hyperthyroidism is a risk factor for SSST.

Related Experiment Videos

Last Updated: Jul 11, 2026

Establishment of a Modified Ferric Chloride-Induced Superior Sagittal Sinus Thrombosis

Establishment of a Modified Ferric Chloride-Induced Superior Sagittal Sinus Thrombosis

Published on: December 30, 2025

Area of Science:

Neurology
Endocrinology
Hematology

Background:

Superior sagittal sinus thrombosis (SSST) is linked to hypercoagulable states.
Hyperthyroidism is known to cause coagulation disturbances, but its direct role in cerebral venous thrombosis remains unclear.

Purpose of the Study:

To investigate the potential association between hyperthyroidism and SSST.
To determine if hyperthyroidism is an independent risk factor for SSST.

Main Methods:

Case report of a 39-year-old male patient presenting with symptoms of increased intracranial pressure, seizures, and rapid atrial fibrillation.
Neuroimaging confirmed SSST.
Laboratory tests indicated hyperthyroidism; other hypercoagulable causes were ruled out.
Patient received prompt treatment for hyperthyroidism.

Main Results:

The patient's neuroimaging revealed SSST.
Laboratory findings were consistent with hyperthyroidism.
Following treatment for hyperthyroidism, the patient experienced sinus recanalization and complete neurological recovery.

Conclusions:

Hyperthyroidism may be an independent risk factor for SSST, potentially due to its effects on factor VIII activity.
Clinicians should consider SSST in hyperthyroid patients with neurological symptoms.
Thyroid dysfunction should be evaluated in patients with unexplained SSST.